200,000+ products from a single source!
sales@angenechem.com
CAS No: 149732-36-5 Catalog No: AG001LZ3 MDL No:
Title | Journal |
---|---|
Synthesis and docking studies of novel antitumor benzimidazoles. | Bioorganic & medicinal chemistry 20121215 |
Effects of urokinase-type plasminogen activator in the acquisition, expression and reinstatement of cocaine-induced conditioned-place preference. | Behavioural brain research 20080805 |
Proteinase activity in human and murine saliva as a biomarker for proteinase inhibitor efficacy. | Clinical cancer research : an official journal of the American Association for Cancer Research 20041201 |
Combined treatment with verapamil, a calcium channel blocker, and B428, a synthetic uPA inhibitor, impairs the metastatic ability of a murine mammary carcinoma. | Oncology reports 20030101 |
Species specificity of amidine-based urokinase inhibitors. | Biochemistry 20010807 |
© 2019 Angene International Limited. All rights Reserved.